These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8154343)

  • 21. Nonpolar interactions of thrombin and its inhibitors at the fibrinogen recognition exosite: thermodynamic analysis.
    Cheng Y; Slon-Usakiewicz JJ; Wang J; Purisima EO; Konishi Y
    Biochemistry; 1996 Oct; 35(40):13021-9. PubMed ID: 8855937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of the N-terminal region of hirudin with the active-site cleft of thrombin.
    Betz A; Hofsteenge J; Stone SR
    Biochemistry; 1992 May; 31(19):4557-62. PubMed ID: 1581311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of rDNA hirudin and alpha-human thrombin hirudin complex in liver and kidney homogenates from rat.
    Grötsch H; Hropot M
    Thromb Res; 1991 Dec; 64(6):763-7. PubMed ID: 1798966
    [No Abstract]   [Full Text] [Related]  

  • 24. Hirulog-1 and -B2 thrombin specificity.
    Witting JI; Bourdon P; Maraganore JM; Fenton JW
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):663-4. PubMed ID: 1445227
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombin-bound conformation of the C-terminal fragments of hirudin determined by transferred nuclear Overhauser effects.
    Ni F; Konishi Y; Scheraga HA
    Biochemistry; 1990 May; 29(18):4479-89. PubMed ID: 2350549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation of the fluorescent amino acid 7-azatryptophan into the core domain 1-47 of hirudin as a probe of hirudin folding and thrombin recognition.
    De Filippis V; De Boni S; De Dea E; Dalzoppo D; Grandi C; Fontana A
    Protein Sci; 2004 Jun; 13(6):1489-502. PubMed ID: 15152084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of hirudin to human alpha, beta and gamma-thrombin. A comparative kinetic and thermodynamic study.
    Ascenzi P; Amiconi G; Coletta M; Lupidi G; Menegatti E; Onesti S; Bolognesi M
    J Mol Biol; 1992 May; 225(1):177-84. PubMed ID: 1374801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Nitrotyrosine as a spectroscopic probe for investigating protein protein interactions.
    De Filippis V; Frasson R; Fontana A
    Protein Sci; 2006 May; 15(5):976-86. PubMed ID: 16641485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qualitative and quantitative detection of human and recombinant thrombin by binding to leech and recombinant hirudin immobilized at the solid phase.
    Fischer BE; Mitterer A; Dorner F
    Thromb Res; 1996 Jan; 81(1):157-62. PubMed ID: 8747531
    [No Abstract]   [Full Text] [Related]  

  • 30. Hirudin and hirudin-based peptides.
    Stone SR; Maraganore JM
    Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
    [No Abstract]   [Full Text] [Related]  

  • 31. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
    De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
    Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrostatic interactions in the association of proteins: an analysis of the thrombin-hirudin complex.
    Karshikov A; Bode W; Tulinsky A; Stone SR
    Protein Sci; 1992 Jun; 1(6):727-35. PubMed ID: 1363935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and identification of recombinant hirudin and its degradation products expressed in Pichia pastoris.
    Zhou WB; Zhang YX
    Prep Biochem Biotechnol; 2004 Aug; 34(3):239-52. PubMed ID: 15461140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of C-terminal-truncated urinary metabolites of a recombinant hirudin in rats.
    Komatsu Y; Hayashi H
    Peptides; 1999 Dec; 20(12):1401-9. PubMed ID: 10698114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncompetitive inhibitor of thrombin.
    Koh CY; Kazimirova M; Nuttall PA; Kini RM
    Chembiochem; 2009 Sep; 10(13):2155-8. PubMed ID: 19644995
    [No Abstract]   [Full Text] [Related]  

  • 36. C-terminal proteolytic degradation of recombinant desulfato-hirudin and its mutants in the yeast Saccharomyces cerevisiae.
    Heim J; Takabayashi K; Meyhack B; Märki W; Pohlig G
    Eur J Biochem; 1994 Dec; 226(2):341-53. PubMed ID: 8001551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic mechanism for the interaction of Hirulog with thrombin.
    Parry MA; Maraganore JM; Stone SR
    Biochemistry; 1994 Dec; 33(49):14807-14. PubMed ID: 7993908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shiga toxin-induced thrombotic microangiopathy: a thrombin-dependent process?
    Tarr P
    Thromb Haemost; 2004 Aug; 92(2):227-8. PubMed ID: 15269815
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrombin interactions with hirudin.
    Fenton JW
    Semin Thromb Hemost; 1989 Jul; 15(3):265-8. PubMed ID: 2688098
    [No Abstract]   [Full Text] [Related]  

  • 40. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.